Cargando…

TARGETING THE MUC1-C ONCOPROTEIN DOWNREGULATES HER2 ACTIVATION AND ABROGATES TRASTUZUMAB RESISTANCE IN BREAST CANCER CELLS

Patients with HER2 positive breast cancer often exhibit intrinsic or acquired resistance to trastuzumab treatment. The transmembrane MUC1-C oncoprotein is aberrantly overexpressed in breast cancer cells and associates with HER2. The present studies demonstrate that silencing MUC1-C in HER2-overexpre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raina, Deepak, Uchida, Yasumitsu, Kharbanda, Akriti, Rajabi, Hasan, Panchamoorthy, Govind, Jin, Caining, Kharbanda, Surender, Scaltriti, Maurizio, Baselga, Jose, Kufe, Donald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916940/ https://www.ncbi.nlm.nih.gov/pubmed/23912457 http://dx.doi.org/10.1038/onc.2013.308

Ejemplares similares

Cooperative Interaction between the MUC1-C Oncoprotein and the Rab31 GTPase in Estrogen Receptor-Positive Breast Cancer Cells
por: Jin, Caining, et al.
Publicado: (2012)

MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells
por: Kharbanda, Akriti, et al.
Publicado: (2014)

Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells
por: Alam, Maroof, et al.
Publicado: (2014)

TARGETING THE eIF4A RNA HELICASE BLOCKS TRANSLATION OF THE MUC1-C ONCOPROTEIN
por: Jin, Caining, et al.
Publicado: (2012)

Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer
por: Ahmad, Rehan, et al.
Publicado: (2017)

MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors
por: Hiraki, Masayuki, et al.
Publicado: (2016)

MUC1-C Oncoprotein Regulates Glycolysis and Pyruvate Kinase m2 Activity in Cancer Cells
por: Kosugi, Michio, et al.
Publicado: (2011)

MUC1-C INTEGRATES PD-L1 INDUCTION WITH REPRESSION OF IMMUNE EFFECTORS IN NON-SMALL CELL LUNG CANCER
por: Bouillez, Audrey, et al.
Publicado: (2017)

Characterization of the MUC1-C Cytoplasmic Domain as a Cancer Target
por: Raina, Deepak, et al.
Publicado: (2015)

Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
por: Hiraki, Masayuki, et al.
Publicado: (2018)

MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia
por: Tagde, Ashujit, et al.
Publicado: (2016)

Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non–neuroendocrine Small Cell Lung Cancer
por: Fushimi, Atsushi, et al.
Publicado: (2022)

COOPERATIVITY OF THE MUC1 ONCOPROTEIN AND STAT1 PATHWAY IN POOR PROGNOSIS HUMAN BREAST CANCER
por: Khodarev, Nikolai, et al.
Publicado: (2009)

DNA METHYLATION BY DNMT1 AND DNMT3b METHYLTRANSFERASES IS DRIVEN BY THE MUC1-C ONCOPROTEIN IN HUMAN CARCINOMA CELLS
por: Rajabi, Hasan, et al.
Publicado: (2016)

MUC1-C ACTIVATES THE TAK1 INFLAMMATORY PATHWAY IN COLON CANCER
por: Takahashi, Hidekazu, et al.
Publicado: (2015)

MUC1‐C drives myeloid leukaemogenesis and resistance to treatment by a survivin‐mediated mechanism
por: Stroopinsky, Dina, et al.
Publicado: (2018)

Role of the MUC1‐C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2020)

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism
por: Fuentes, Gloria, et al.
Publicado: (2011)

Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells
por: Hasegawa, Masanori, et al.
Publicado: (2016)

MUC1-C drives DNA methylation in cancer
por: Rajabi, Hasan, et al.
Publicado: (2016)

Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression
por: Bruni, Sofia, et al.
Publicado: (2023)

Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer
por: Li, Wei, et al.
Publicado: (2022)

MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas
por: Luan, Zhou, et al.
Publicado: (2021)

Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth
por: Chandarlapaty, Sarat, et al.
Publicado: (2009)

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein
por: Jochems, Caroline, et al.
Publicado: (2013)

MUC1 is an oncoprotein with a significant role in apoptosis (Review)
por: Supruniuk, Katarzyna, et al.
Publicado: (2021)

MUC1-C REPRESSES THE RASSF1A TUMOR SUPPRESSOR IN HUMAN CARCINOMA CELLS
por: Rajabi, Hasan, et al.
Publicado: (2019)

Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis
por: Lewis Phillips, Gail D., et al.
Publicado: (2017)

Correction: MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells
por: Rajabi, Hasan, et al.
Publicado: (2019)

Emergence of MUC1 in Mammals for Adaptation of Barrier Epithelia
por: Kufe, Donald W.
Publicado: (2022)

Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer
por: Kufe, Donald
Publicado: (2023)

MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
por: Yasumizu, Yota, et al.
Publicado: (2020)

Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma
por: Tagde, Ashujit, et al.
Publicado: (2017)

Molecular docking analysis of compounds from Justica adhatoda L with the MUC1 oncoprotein
por: Govindan, Ramajayam, et al.
Publicado: (2020)

Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer
por: Mercogliano, María F., et al.
Publicado: (2017)

MUC1-C activates EZH2 expression and function in human cancer cells
por: Rajabi, Hasan, et al.
Publicado: (2017)

Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression
por: Li, Guangchao, et al.
Publicado: (2014)

Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
por: Yasumizu, Yota, et al.
Publicado: (2020)

MUC1-C ACTIVATES BMI1 IN HUMAN CANCER CELLS
por: Hiraki, Masayuki, et al.
Publicado: (2016)

MUC1 Oncoprotein Mitigates ER Stress via CDA-mediated Reprogramming of Pyrimidine Metabolism
por: Olou, Appolinaire A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2a201k6mbt0jq3477bgj0vohve